GGrantIndex
Sort

64,565 grants matching drug discovery

Computational Pathology Research for Cancer Modeling, Diagnostics and Biomarkers

$1,895,307
Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Telomere Biology

$1,895,177
Julia Cooper · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency

$1,894,047
David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · DK

Defining and Manipulating Epigenomic Regulators in Endogenous Systems

$1,893,252
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Glucocorticoid Hormone Action

$1,893,109
John A. Cidlowski · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

DCTD Preclinical In Vivo/In Vitro Assay Development

$1,893,000
Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA

Identifying the genetic causes of depression in a deeply phenotyped population from South Korea

$1,892,866
Jonathan Flint · University Of California Los Angeles · U01 · FY2023 · MH

Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP

$1,892,819
Alison M Goate · Icahn School Of Medicine At Mount Sinai · U54 · FY2021 · NS

Vanderbilt NCDDDG for Discovery of Novel Treatments for Schizophrenia

$1,891,522
P Jeffrey Conn · Vanderbilt University · U01 · FY2010 · MH

Trans-America Consortium of the Health Care Systems Research Network for the Precision Medicine Initiative Cohort Program

$1,890,835
Christine C Johnson · Henry Ford Health System · OT2 · FY2016 · OD

Chromatin Structure and Gene Expression

$1,890,480
Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Sickle cell disease molecular pathogenesis and drug therapy

$1,890,416
William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Probing neuroinflammation in Alzheimer's disease with NLRP3 PET radiotracers

$1,889,973
Shijun Zhang · Virginia Commonwealth University · RF1 · FY2023 · AG

Pharmacokinetics and Drug Metabolism

$1,889,528
Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

Vesicle-mediated drug resistance of Candida albicans biofilm

$1,889,324
David R Andes · University Of Wisconsin-Madison · R01 · FY2025 · AI

Translational Immunology research: a support for clinical immunological research

$1,889,188
Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2021 · AR

Targeting Signal Transduction Pathways for Cancer Drug Discovery

$1,888,951
Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2008 · CA

A New Disease Platform Leveraging Complex Drosophila and Mammalian Models

$1,888,720
Ross Leigh Cagan · Icahn School Of Medicine At Mount Sinai · U54 · FY2017 · OD

A genomewide study of lung cancer in never smokers

$1,888,628
Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA

Computational Biology, Bioinformatics, Imaging & Proteomics Research-RCMI

$1,888,040
William M Southerland · Howard University · G12 · FY2012 · MD

ANTIVIRAL DRUG DISCOVERY TARGETING ZIKA VIRUS PROTEASE

$1,887,373
Baylor College Of Medicine · · FY2018 · Defense Health Agency

Disease mechanism and therapies for retinal degeneration

$1,886,549
Tiansen Li · National Eye Institute · ZIA · FY2020 · EY

Infrastructure to improve reliability of AMP-AD target hypotheses

$1,885,852
Lara M Mangravite · Sage Bionetworks · RF1 · FY2018 · AG

PD iPS Cell Line Research Consortium

$1,885,510
Ole Isacson · Mclean Hospital · RC2 · FY2009 · NS

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

$1,884,842
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA